De novo Mutations From Whole Exome Sequencing in Neurodevelopmental and Psychiatric Disorders: From Discovery to Application
暂无分享,去创建一个
[1] G. Bejerano,et al. Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers , 2016, Genetics in Medicine.
[2] C. Kimchi-Sarfaty,et al. Synonymous Mutations as a Cause of Human Genetic Disease , 2013 .
[3] K. Boycott,et al. Rare-disease genetics in the era of next-generation sequencing: discovery to translation , 2013, Nature Reviews Genetics.
[4] Tanya M. Teslovich,et al. Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.
[5] Bradley P. Coe,et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.
[6] Vineet Bafna,et al. Exome Sequencing Can Improve Diagnosis and Alter Patient Management , 2012, Science Translational Medicine.
[7] K. Helbig,et al. Classification of Genes: Standardized Clinical Validity Assessment of Gene–Disease Associations Aids Diagnostic Exome Analysis and Reclassifications , 2017, Human mutation.
[8] Boris Yamrom,et al. The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.
[9] Kathryn Roeder,et al. Integrated Model of De Novo and Inherited Genetic Variants Yields Greater Power to Identify Risk Genes , 2013, PLoS genetics.
[10] L. Vissers,et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.
[11] Jianxin Shi,et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.
[12] Christian Gilissen,et al. A de novo paradigm for mental retardation , 2010, Nature Genetics.
[13] Y. Kamatani,et al. A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder , 2017, Molecular Psychiatry.
[14] Olivier Rouaud,et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases , 2017, PLoS medicine.
[15] Kenny Q. Ye,et al. De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.
[16] Daniel H. Geschwind,et al. Neuroscience in the era of functional genomics and systems biology , 2009, Nature.
[17] A. Afenjar,et al. SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort , 2016, Journal of Medical Genetics.
[18] Keith Nykamp,et al. Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria , 2017, Genetics in Medicine.
[19] J. Sebat,et al. CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics , 2012, Cell.
[20] Michael F. Walker,et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.
[21] M. Rieder,et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2011, Nature Genetics.
[22] M. Black,et al. Outcomes of Diagnostic Exome Sequencing in Patients With Diagnosed or Suspected Autism Spectrum Disorders. , 2017, Pediatric neurology.
[23] Trey Ideker,et al. Genotype to phenotype via network analysis. , 2013, Current opinion in genetics & development.
[24] David Haussler,et al. Improved splice site detection in Genie , 1997, RECOMB '97.
[25] Haiyuan Yu,et al. Interactome INSIDER: a structural interactome browser for genomic studies , 2017, Nature Methods.
[26] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[27] F. Gnad,et al. Assessment of computational methods for predicting the effects of missense mutations in human cancers , 2013, BMC Genomics.
[28] D. G. MacArthur,et al. Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.
[29] João Pedro de Magalhães,et al. Gene co-expression analysis for functional classification and gene–disease predictions , 2017, Briefings Bioinform..
[30] Samuel S. Gross,et al. Genome-wide characteristics of de novo mutations in autism , 2016, npj Genomic Medicine.
[31] Christopher S. Poultney,et al. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia , 2017, Molecular Autism.
[32] David R. Murdock,et al. Whole-Genome Sequencing for Optimized Patient Management , 2011, Science Translational Medicine.
[33] Xiaohua Liu,et al. Switch from previous major depression comorbid with CLIPPERS to mania-like episode following glucocorticosteroid therapy: a case report , 2018, General Psychiatry.
[34] A. Heguy,et al. De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample , 2015, Schizophrenia Research.
[35] I. Helbig,et al. Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy , 2016, Genetics in Medicine.
[36] J. Hampe,et al. Single base‐pair substitutions in exon–intron junctions of human genes: nature, distribution, and consequences for mRNA splicing , 2007, Human mutation.
[37] Jana Marie Schwarz,et al. MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.
[38] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[39] Eric Boerwinkle,et al. In silico tools for splicing defect prediction - A survey from the viewpoint of end-users , 2013, Genetics in Medicine.
[40] Yaping Yang,et al. Two de novo novel mutations in one SHANK3 allele in a patient with autism and moderate intellectual disability , 2018, American journal of medical genetics. Part A.
[41] Patrick F. Sullivan,et al. Genetic architectures of psychiatric disorders: the emerging picture and its implications , 2012, Nature Reviews Genetics.
[42] S. Levy,et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia , 2011, Nature Genetics.
[43] Ron Shamir,et al. Dissection of Regulatory Networks that Are Altered in Disease via Differential Co-expression , 2013, PLoS Comput. Biol..
[44] Peter M Visscher,et al. Large-scale genomics unveils the genetic architecture of psychiatric disorders , 2014, Nature Neuroscience.
[45] Martin Offringa,et al. Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness , 2005, European Journal of Human Genetics.
[46] Kali T. Witherspoon,et al. Recurrent de novo mutations implicate novel genes underlying simplex autism risk , 2014, Nature Communications.
[47] Leopold Parts,et al. Computational biology: deep learning , 2017, Emerging topics in life sciences.
[48] Edwin Reyniers,et al. A point mutation in the FMR-1 gene associated with fragile X mental retardation , 1993, Nature Genetics.
[49] Tyrone D. Cannon,et al. GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium , 2017, Molecular Psychiatry.
[50] D. Rujescu,et al. Exome Sequencing in 53 Sporadic Cases of Schizophrenia Identifies 18 Putative Candidate Genes , 2014, PloS one.
[51] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[52] V. Willour,et al. Exome Sequencing of Familial Bipolar Disorder. , 2016, JAMA psychiatry.
[53] A. Singleton,et al. Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations , 2014, Human molecular genetics.
[54] Lilia M. Iakoucheva,et al. Paternally inherited cis-regulatory structural variants are associated with autism , 2018, Science.
[55] Michael R. Johnson,et al. De novo mutations in the classic epileptic encephalopathies , 2013, Nature.
[56] Christopher S. Poultney,et al. Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.
[57] Joshua M. Stuart,et al. A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules , 2003, Science.
[58] P. Stenson,et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies , 2017, Human Genetics.
[59] Stephan J Sanders,et al. Whole-exome sequencing in obsessive-compulsive disorder identifies rare mutations in immunological and neurodevelopmental pathways , 2016, Translational Psychiatry.
[60] L. Furlong. Human diseases through the lens of network biology. , 2013, Trends in genetics : TIG.
[61] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[62] Stephen J. Guter,et al. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism , 2017, Molecular Autism.
[63] Ruslan Salakhutdinov,et al. Learning Deep Generative Models , 2009 .
[64] W. Barbaresi,et al. The Yield of the Medical Evaluation of Children with Pervasive Developmental Disorders , 2003, Journal of autism and developmental disorders.
[65] Wei Li,et al. mirDNMR: a gene-centered database of background de novo mutation rates in human , 2016, Nucleic Acids Res..
[66] Jean-Daniel Zucker,et al. Interactional and functional centrality in transcriptional co-expression networks , 2010, Bioinform..
[67] S. Salzberg,et al. GeneSplicer: a new computational method for splice site prediction. , 2001, Nucleic acids research.
[68] S. Scherer,et al. Heterogeneity in clinical sequencing tests marketed for autism spectrum disorders , 2018, npj Genomic Medicine.
[69] Chunyu Liu,et al. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database , 2016, Molecular Psychiatry.
[70] Bradley P. Coe,et al. Recurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications , 2017, Genome Medicine.
[71] Zhong Sheng Sun,et al. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database , 2016, Molecular Psychiatry.
[72] Seungtai Yoon,et al. De novo Mutations in Schizophrenia Implicate Chromatin Remodeling and Support a Genetic Overlap with Autism and Intellectual Disability , 2014, Molecular Psychiatry.
[73] J. Crow. The origins, patterns and implications of human spontaneous mutation , 2000, Nature Reviews Genetics.
[74] Isabelle Cleynen,et al. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease , 2011, Nature Genetics.
[75] Orion J. Buske,et al. The Matchmaker Exchange: A Platform for Rare Disease Gene Discovery , 2015, Human mutation.
[76] J. Sebat,et al. Spatiotemporal 16p11.2 Protein Network Implicates Cortical Late Mid-Fetal Brain Development and KCTD13-Cul3-RhoA Pathway in Psychiatric Diseases , 2015, Neuron.
[77] Lilia M. Iakoucheva,et al. Whole-Genome Sequencing in Autism Identifies Hot Spots for De Novo Germline Mutation , 2012, Cell.
[78] C. Gillberg,et al. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. , 2010, The American journal of psychiatry.
[79] S. Scherer,et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. , 2013, American journal of human genetics.
[80] B. Frey,et al. Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning , 2015, Nature Biotechnology.
[81] S. Horvath,et al. Statistical Applications in Genetics and Molecular Biology , 2011 .
[82] M. K. Rudd,et al. Human Structural Variation: Mechanisms of Chromosome Rearrangements. , 2015, Trends in genetics : TIG.
[83] T. Cowan,et al. Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics , 2017, Genetics in Medicine.
[84] Tudor Groza,et al. The Human Phenotype Ontology in 2017 , 2016, Nucleic Acids Res..
[85] A. Singleton,et al. A systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease , 2015, Human molecular genetics.
[86] A. Malhotra,et al. Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic , 2015, Molecular Psychiatry.
[87] Magalie S Leduc,et al. Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.
[88] Karynne E. Patterson,et al. Sequencing of sporadic Attention‐Deficit Hyperactivity Disorder (ADHD) identifies novel and potentially pathogenic de novo variants and excludes overlap with genes associated with autism spectrum disorder , 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[89] R. Plomin,et al. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. , 2008, Journal of child psychology and psychiatry, and allied disciplines.
[90] Janice M. Fullerton,et al. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder , 2016, bioRxiv.
[91] A. Need,et al. One gene, many neuropsychiatric disorders: lessons from Mendelian diseases , 2014, Nature Neuroscience.
[92] O. Troyanskaya,et al. Predicting effects of noncoding variants with deep learning–based sequence model , 2015, Nature Methods.
[93] Pall I. Olason,et al. Integrative analysis for finding genes and networks involved in diabetes and other complex diseases , 2007, Genome Biology.
[94] Kali T. Witherspoon,et al. Excess of rare, inherited truncating mutations in autism , 2015, Nature Genetics.
[95] Pieter B. T. Neerincx,et al. Supplementary Information Whole-genome sequence variation , population structure and demographic history of the Dutch population , 2022 .
[96] Jeroen F. J. Laros,et al. LOVD v.2.0: the next generation in gene variant databases , 2011, Human mutation.
[97] L. Kaczmarek,et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy , 2012, Nature Genetics.
[98] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[99] Dustin Baldridge,et al. The Exome Clinic and the Role of Medical Genetics Expertise in Interpretation of Exome Sequencing Results , 2017, Genetics in Medicine.
[100] Soo-Mi Park,et al. De novo, heterozygous, loss‐of‐function mutations in SYNGAP1 cause a syndromic form of intellectual disability , 2015, American journal of medical genetics. Part A.
[101] Jeffrey D. Mandell,et al. De Novo Coding Variants Are Strongly Associated with Tourette Syndrome , 2019, European Neuropsychopharmacology.
[102] Serafim Batzoglou,et al. Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..
[103] S. Vernes,et al. Understanding Neurodevelopmental Disorders: The Promise of Regulatory Variation in the 3′UTRome , 2017, Biological Psychiatry.
[104] L. Siever,et al. Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network , 2013, Cell.
[105] T. Andrews,et al. Comparison of predicted and actual consequences of missense mutations , 2015, Proceedings of the National Academy of Sciences.
[106] Kali T. Witherspoon,et al. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID , 2016, Molecular Psychiatry.
[107] Zev N. Kronenberg,et al. De novo genic mutations among a Chinese autism spectrum disorder cohort , 2016, Nature Communications.
[108] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[109] Edouard Henrion,et al. De Novo Mutations in Moderate or Severe Intellectual Disability , 2014, PLoS genetics.
[110] N. Matoba,et al. Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations , 2016, Molecular Psychiatry.
[111] N. Carter,et al. Deciphering Developmental Disorders , 2012 .
[112] Ryan L. Collins,et al. An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder , 2018, Nature Genetics.
[113] M. Fukunaga,et al. Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder , 2015, Journal of Human Genetics.
[114] Shannon E. Ellis,et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism , 2014, Nature Communications.
[115] Hoang T. Nguyen,et al. Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders , 2017, Genome Medicine.
[116] Zachary F. Gerring,et al. GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability , 2018, Nature Neuroscience.
[117] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[118] Katherine Payne,et al. Cost-effectiveness analyses of genetic and genomic diagnostic tests , 2018, Nature Reviews Genetics.
[119] Ricardo Villamarín-Salomón,et al. ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..
[120] H. Bickeböller,et al. Case‐Control Association Tests Correcting for Population Stratification , 2006, Annals of human genetics.
[121] Eric Vilain,et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.
[122] Caroline F. Wright,et al. De novo mutations in regulatory elements in neurodevelopmental disorders , 2018, Nature.
[123] D. Goldstein,et al. Sequencing studies in human genetics: design and interpretation , 2013, Nature Reviews Genetics.
[124] Patrick F Sullivan,et al. Genome-wide association studies in psychiatry: what have we learned? , 2013, British Journal of Psychiatry.
[125] M. DePristo,et al. Deep learning of genomic variation and regulatory network data. , 2018, Human molecular genetics.
[126] Bradley P. Coe,et al. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.
[127] Chunyu Liu,et al. A Decade in Psychiatric GWAS Research , 2018, Molecular Psychiatry.
[128] J. Valcárcel,et al. The pathogenicity of splicing defects: mechanistic insights into pre‐mRNA processing inform novel therapeutic approaches , 2015, EMBO reports.
[129] C. Spencer,et al. Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.
[130] S. Horvath,et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap , 2016, Science.
[131] N. Kato,et al. Genome‐wide Association Study of Autism Spectrum Disorder in the East Asian Populations , 2016, Autism research : official journal of the International Society for Autism Research.
[132] Kenny Q. Ye,et al. Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.
[133] S. Faraone,et al. Examining the comorbidity between attention deficit hyperactivity disorder and bipolar I disorder: a meta-analysis of family genetic studies. , 2012, The American journal of psychiatry.
[134] Wei Niu,et al. Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism , 2013, Cell.
[135] U. Moog. The outcome of diagnostic studies on the etiology of mental retardation: Considerations on the classification of the causes , 2005, American journal of medical genetics. Part A.
[136] K. Veeramah,et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies , 2013, Epilepsia.
[137] Dan J Stein,et al. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.
[138] Jonathan Sebat,et al. SV2: Accurate Structural Variation Genotyping and De Novo Mutation Detection from Whole Genomes , 2017, bioRxiv.
[139] Santhosh Girirajan,et al. Human copy number variation and complex genetic disease. , 2011, Annual review of genetics.
[140] Shahar Shohat,et al. Varying Intolerance of Gene Pathways to Mutational Classes Explain Genetic Convergence across Neuropsychiatric Disorders. , 2017, Cell reports.
[141] Ayellet V. Segrè,et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.
[142] S. Horvath,et al. Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism , 2013, Cell.
[143] J. Lupski,et al. Genetics and genomics of behavioral and psychiatric disorders. , 2003, Current opinion in genetics & development.
[144] Patrick Callier,et al. Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis , 2017, Genetics in Medicine.
[145] Clinical Utility , 2020, Encyclopedia of Personality and Individual Differences.
[146] A. Battaglia,et al. Diagnostic evaluation of developmental delay/mental retardation: An overview , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.
[147] Daniele Merico,et al. Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder. , 2015, JAMA.
[148] T. Ideker,et al. Integrative approaches for finding modular structure in biological networks , 2013, Nature Reviews Genetics.
[149] L. Vissers,et al. Genome sequencing identifies major causes of severe intellectual disability , 2014, Nature.
[150] S. Levy,et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia , 2012, Nature Genetics.
[151] Charles F. Bearden,et al. A Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease Risk , 2013, Cell.
[152] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[153] David R. FitzPatrick,et al. Paediatric genomics: diagnosing rare disease in children , 2018, Nature Reviews Genetics.
[154] P. Radivojac,et al. MutPred Splice: machine learning-based prediction of exonic variants that disrupt splicing , 2014, Genome Biology.
[155] Jan K. Buitelaar,et al. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder , 2010, European Child & Adolescent Psychiatry.
[156] Alkes L. Price,et al. New approaches to population stratification in genome-wide association studies , 2010, Nature Reviews Genetics.
[157] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[158] A. Siepel,et al. Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data , 2016, Nature Genetics.
[159] L. Feuk,et al. Mutations in HECW2 are associated with intellectual disability and epilepsy , 2016, Journal of Medical Genetics.
[160] Trevor Hastie,et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. , 2016, American journal of human genetics.
[161] A. Syvänen,et al. De novo mutations implicate novel genes in systemic lupus erythematosus , 2017, Human molecular genetics.
[162] P. Sullivan,et al. Family history of schizophrenia and bipolar disorder as risk factors for autism. , 2012, Archives of general psychiatry.
[163] Yi Zhang,et al. Performance evaluation of pathogenicity-computation methods for missense variants , 2018, Nucleic acids research.
[164] Giulio Genovese,et al. Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia , 2016, Nature Neuroscience.
[165] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[166] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[167] Michael L. Creech,et al. Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.
[168] Y. Fang,et al. Analysis of Misdiagnosis of Bipolar Disorder in An Outpatient Setting , 2018, General Psychiatry.
[169] C. Baker,et al. Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA. , 2016, American journal of human genetics.
[170] Deciphering Developmental Disorders Study,et al. Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.
[171] Leslie G Biesecker,et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.
[172] Sharmila Banerjee-Basu,et al. SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs) , 2013, Molecular Autism.
[173] Bradley P. Coe,et al. Targeted sequencing identifies 91 neurodevelopmental disorder risk genes with autism and developmental disability biases , 2017, Nature Genetics.
[174] H. Carter,et al. Identifying Mendelian disease genes with the Variant Effect Scoring Tool , 2013, BMC Genomics.
[175] A. Battaglia,et al. Diagnostic yield of the comprehensive assessment of developmental delay/mental retardation in an institute of child neuropsychiatry. , 1999, American journal of medical genetics.
[176] Joshua L. Deignan,et al. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. , 2014, JAMA neurology.
[177] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[178] S. Kingsmore,et al. Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Become Routine? , 2011, Science Translational Medicine.
[179] P. Visscher,et al. Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease , 2013, Nature Genetics.
[180] V. Calhoun,et al. A pilot study on commonality and specificity of copy number variants in schizophrenia and bipolar disorder , 2016, Translational Psychiatry.
[181] I. Ionita-Laza,et al. Loss-of-Function Variants in Schizophrenia Risk and SETD1A as a Candidate Susceptibility Gene , 2014, Neuron.
[182] Allyn McConkie-Rosell,et al. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders , 2013, Genetics in Medicine.
[183] Xiang Li,et al. Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions , 2014, Genetics in Medicine.
[184] Raphael A. Bernier,et al. denovo-db: a compendium of human de novo variants , 2016, Nucleic Acids Res..
[185] Epilepsy Phenome,et al. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.
[186] P. Stankiewicz,et al. Structural variation in the human genome and its role in disease. , 2010, Annual review of medicine.
[187] S. Scherer,et al. Whole-genome sequencing of quartet families with autism spectrum disorder , 2015, Nature Medicine.
[188] Luis de la Torre Ubieta,et al. Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism , 2016, Nature.
[189] Christopher S. Poultney,et al. Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.
[190] R. Gibbs,et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. , 2015, Human molecular genetics.
[191] E. Boerwinkle,et al. dbNSFP v3.0: A One‐Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice‐Site SNVs , 2016, Human mutation.
[192] J. Buxbaum,et al. A SPECTRAL APPROACH INTEGRATING FUNCTIONAL GENOMIC ANNOTATIONS FOR CODING AND NONCODING VARIANTS , 2015, Nature Genetics.
[193] Francisco S. Roque,et al. A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes , 2008, Proceedings of the National Academy of Sciences.
[194] Meghan C Towne,et al. A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia , 2016, Cold Spring Harbor molecular case studies.
[195] Evan T. Geller,et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.
[196] De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity , 2017, Scientific Reports.
[197] S. Lok,et al. Increased exonic de novo mutation rate in individuals with schizophrenia , 2011, Nature Genetics.
[198] Clara Gaff,et al. Patient safety in genomic medicine: an exploratory study , 2016, Genetics in Medicine.
[199] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[200] S. Weng,et al. What’s in the pipeline? Drugs in development for autism spectrum disorder , 2014, Neuropsychiatric disease and treatment.
[201] M. Daly,et al. Proteins Encoded in Genomic Regions Associated with Immune-Mediated Disease Physically Interact and Suggest Underlying Biology , 2011, PLoS genetics.
[202] Gert Jan van der Wilt,et al. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology , 2017, Genetics in Medicine.
[203] R. Moldovan,et al. Complementarity between medical geneticists and genetic counsellors: its added value in genetic services in Europe , 2017, European Journal of Human Genetics.
[204] Patrick F Sullivan,et al. The Psychiatric GWAS Consortium: Big Science Comes to Psychiatry , 2010, Neuron.
[205] M. De Hert,et al. Lujan-Fryns syndrome in the differential diagnosis of schizophrenia. , 1996, American journal of medical genetics.
[206] Hyejung Won,et al. The road to precision psychiatry: translating genetics into disease mechanisms , 2016, Nature Neuroscience.
[207] Stephan J Sanders,et al. A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.
[208] Daniel H. Geschwind,et al. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders , 2015, Nature Reviews Genetics.
[209] François Dubeau,et al. High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. , 2017, American journal of human genetics.
[210] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[211] Jeffrey D. Mandell,et al. De Novo Coding Variants Are Strongly Associated with Tourette Disorder , 2017, Neuron.
[212] P. Visscher,et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.
[213] D. Horn,et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.
[214] P. Visscher,et al. Five years of GWAS discovery. , 2012, American journal of human genetics.
[215] C. Betancur,et al. Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting , 2011, Brain Research.
[216] J. R. MacDonald,et al. A Comprehensive Workflow for Read Depth-Based Identification of Copy-Number Variation from Whole-Genome Sequence Data. , 2018, American journal of human genetics.
[217] J. Veltman,et al. De novo mutations in human genetic disease , 2012, Nature Reviews Genetics.
[218] Karsten M. Borgwardt,et al. The Evaluation of Tools Used to Predict the Impact of Missense Variants Is Hindered by Two Types of Circularity , 2015, Human mutation.
[219] James T Lu,et al. Genotype-phenotype correlation--promiscuity in the era of next-generation sequencing. , 2014, The New England journal of medicine.
[220] W. McMahon,et al. Genetic and phenotypic overlap of specific obsessive-compulsive and attention-deficit/hyperactive subtypes with Tourette syndrome , 2017, Psychological Medicine.
[221] E. Banks,et al. De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.
[222] J. Shendure,et al. Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.
[223] Colin Campbell,et al. An integrative approach to predicting the functional effects of non-coding and coding sequence variation , 2015, Bioinform..
[224] Dennis Vitkup,et al. Diverse types of genetic variation converge on functional gene networks involved in schizophrenia , 2012, Nature Neuroscience.
[225] Christopher S. Poultney,et al. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia , 2017, Molecular Autism.
[226] B. Frey,et al. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder , 2017, Nature Neuroscience.